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The relationship between acidosis within the tumor microenvironment and radioresistance
of hypoxic tumor cells remains unclear. Previously we reported that hypoxia-induced car-
bonic anhydrases (CA) IX and CAXII constitute a robust intracellular pH (pHi)-regulating
system that confers a survival advantage on hypoxic human colon carcinoma LS174Tr cells
in acidic microenvironments. Here we investigate the role of acidosis, CAIX and CAXII
knock-down in combination with ionizing radiation. Fibroblasts cells (−/+ CAIX) and LS174Tr
cells (inducible knock-down for ca9/ca12) were analyzed for cell cycle phase distribution
and survival after irradiation in extracellular pHo manipulations and hypoxia (1% O2) expo-
sure. Radiotherapy was used to target ca9/ca12-silenced LS174Tr tumors grown in nude
mice.We found that diminishing the pHi-regulating capacity of ﬁbroblasts through inhibition
of Na+/H+ exchanger 1 sensitize cells to radiation-induced cell death. Secondly, the pHi-
regulating function of CAIX plays a key protective role in irradiated ﬁbroblasts in an acidic
environment as accompanied by a reduced number of cells in the radiosensitive phases
of the cell cycle. Thirdly, we demonstrate that irradiation of LS174Tr spheroids, silenced
for either ca9 or both ca9/ca12, showed a respective 50 and 75% increase in cell death
as a result of a decrease in cell number in the radioresistant S phase and a disruption
of CA-mediated pHi regulation. Finally, LS174Tr tumor progression was strongly decreased
when ca9/ca12 silencing was combined with irradiation in vivo.These ﬁndings highlight the
combinatory use of radiotherapy with targeting of the pHi-regulating CAs as an anti-cancer
strategy.
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INTRODUCTION
Ionizing radiation is used therapeutically to induce cancer cell
death, decrease distant metastasis rates, and to increase over-
all patient survival (Darby et al., 2011). However, radiotherapy
does not efﬁciently target all cells of the tumor mass. Tumor cell
re-population and activation of DNA repair mechanisms (ATM,
γH2AX, and p53) are key components of tumor cell radioresis-
tance (Huen and Chen, 2008). Cells in the G2/M and G1 phases of
the cell cycle have been shown to be the most radiosensitive, while
cells in the S phase are radioresistant (Hwang et al., 2000; Paw-
lik and Keyomarsi, 2004). The latter is attributed to DNA double
strand breaks (DSBs) repair systems such as homologous recombi-
nation that occur in the S phase (Kastan and Bartek, 2004; Jackson
and Bartek, 2009). In the 1950s, several groups established the
connection between hypoxia and radioresistance in mammalian
tumors (Deschner and Gray, 1959; Dewey, 1960) and oxygen
levels remain the major cell radiosensitizer known to date. In
well-oxygenated conditions, the free radicals generated by ion-
izing radiation insult react with O2 to form peroxy radicals that
damage DNA much more efﬁciently than reduced free radicals
(Brown, 2007). Consequently, the poorly oxygenated (hypoxic)
cells of tumors are more radioresistant (Gray, 1953). These studies
led to the general hypothesis that oxygen acts at a physicochemical
level to improve radiation induced damage as a consequence of
the high afﬁnity between the oxygen molecule and the unpaired
electron on the free radical produced by radiation.
In addition to low oxygen, increased acidiﬁcation is also a hall-
mark of hypoxic tumors and it has been suggested to play an
indirect role in the poor radioresponse of hypoxic tumors (Vau-
pel, 2004). In contrast, another report indicates that extracellular
acidosis may enhance radiosensitivity in combination with lactate
accumulation for certain cell lines (Grotius et al., 2009). How-
ever, lactate accumulation alone (in the absence of pH disruption)
has also been suggested to reduce radiosensitivity of tumor cells
(Quennet et al., 2006). Furthermore, the effect of intracellular pH
(pHi) and extracellular pH (pHo) regulation on the efﬁcacy of
irradiation remains to be clariﬁed.
Despite the fact that all mammalian cells are capable of pro-
tecting their cytosol from acidiﬁcation through expression of
membrane located transporters and exchangers including the
Na+/H+ exchanger 1 (NHE-1; Pouysségur et al., 1985) and the
monocarboxylate transporter 1 (MCT1; Halestrap and Price,
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1999), hypoxic tumor cells have developed additional mecha-
nisms to regulate their pHi (Chiche et al., 2010b). In solid tumors,
membrane-bound carbonic anhydrases (CA) IX and XII are con-
trolled by oxygen levels via the hypoxia-inducible factor (HIF-1;
Wykoff et al., 2000) and catalyze at the cell surface the reversible
hydration of carbon dioxide (CO2) into a proton (H+) and bicar-
bonate (HCO−3 ). Once generated,HCO
−
3 is proposed to be rapidly
taken up into the cell through the Na+–HCO−3 cotransporters
(NBC; Romero et al., 2004; Parks et al., 2011) to sustain a slightly
alkaline pHi compatible with cell survival (Morgan et al., 2007;
Swietach et al., 2009; Chiche et al., 2010a). Many reports correlate
CAIX expression with poor patient survival in a variety of cancers
(see review Supuran, 2008; Chiche et al., 2010a). The extracellular
location of the CAIX active site together with its overexpression in
hypoxic cancer cells compared to minimal expression in healthy
cells, except in the gastro-intestinal tract and the stomach (Pas-
toreková et al., 1997) makes hypoxia-induced CAIX an accessible
target for new anti-cancer therapy (Supuran, 2008; Morris et al.,
2011). CAIX function has been clearly established to contribute
to extracellular acidiﬁcation (Svastová et al., 2004). In addition,
studies in our laboratory have characterized CAIX and CAXII as
robust pHi-regulating enzymes and have provided evidence that
both CAIX and CAXII hold potential as new anti-cancer targets
(Chiche et al., 2010a).
We analyzed the downstream effects of CAIX and CAXII
activity on radiation-induced cell death to determine whether a
combined therapy of irradiation and down-regulation of CAIX
and CAXII would sensitize hypoxic cells to ionizing radiation.
An alteration in pHi regulation (either by inhibition of NHE-1 or
expression of CAIX) revealed a decreased percentage in cells found
in the radioresistant S phase and an in vitro radiosensitization that
correlated with an increase in cell death. Gene silencing of ca9
and ca9/ca12 revealed in vitro and in vivo radiosensitization as a
consequence of a reduction of cells in the S phase and a decrease
in the pHi-regulating capacity of the cell.
MATERIALS AND METHODS
CELL CULTURE AND HYPOXIC EXPOSURE
Chinese hamster lung CCL39 ﬁbroblasts (ATCC), CCL39-derived
PS120 cells lacking NHE-1, and CAIX and CAXII, were cultured
as described. Colon adenocarcinoma LS174Tr cells expressing the
tetracycline (Tet) repressor were maintained in Dulbecco’s modi-
ﬁed Eagle’s medium (DMEM) supplemented with 10% fetal calf
serum (FCS) and blasticidin (10 μg/ml, Invitrogen). Incubation
in hypoxia at 1% O2 was carried out at 37◦C in 95% humidity and
5% CO2/94% N2 in a sealed anaerobic workstation (Ruskinn).
CELL IRRADIATION
Irradiation of normoxic cells was performed in 25 cm2 ventilated
ﬂasks (Nunc), while irradiation of hypoxic cells was performed in
25 cm2 non-ventilated ﬂasks to maintain 1% O2 during treatment
after removal from the hypoxic workstation. Cells were irradiated
100 cm from the source with a bolus of 1.1 cm (under dishes).
High energy photons were used (6 MV), delivered by a linear
accelerator (PRIMUS®, Siemens) with a 40 cm × 40 cm posterior
ﬁeld. The dose rate of the PRIMUS was 300 monitor units/min
and 2 Gy corresponded to 93 monitor units (18.6 s). Spheroids
were irradiated with the same schedule but with an anterior ﬁeld
and a bolus placed at the top of the dishes.
PLASMIDS
Full-length human ca9 cDNA was obtained and inserted
into pTREX-A (pcDNA4/TO/myc-His A; Invitrogen; pca9) as
described (Chiche et al., 2010a). The short-hairpin (sh) RNA-
ca9 (shca9) was obtained with oligonucleotides: forward 5′-
AGTTAAGCCTAAATCAGAA-3′ and reverse 5′TTCTGATTTA-
GGCTTAACT-3′ and inserted into either pTERvector (alsonamed
shca9). Lentivirus particles for two independent sequences (#1
and #2) of pLKO.1-Puro shRNA targeting ca12 (ca12−) and non-
target shRNA (ctl; Sigma, TRCN0000116249, TRCN0000116251,
and SHC002V) were used to constitutively silence ca12.
STABLE TRANSGENIC CELLS
PS120 cells were transfected with pca9 as described (Chiche et al.,
2010a). Tet (10 μg/ml)-inducible LS174Tr cells silenced for ca9
(LS-shca9/ctl) combined with a constitutive silencing of ca12 (LS-
shca9/ca12−) were obtained as described (Chiche et al., 2010a).
IMMUNOBLOTTING
Cells were lysed in 1.5 × SDS sample buffer. Proteins (40 μg) were
separated on 7.5% SDS polyacrylamide gels and transferred onto
polyvinylidene diﬂuoride membranes (Millipore). Membranes
were blotted with the M75 antibody to CAIX (Bayer), a poly-
clonal antibody to recombinant CAXII (Sigma), p21 (Santa Cruz),
β1 integrin (Cell Signalling), and Hsp90 (Abcam). Immunore-
active bands were detected with a horseradish peroxidase-anti-
mouse or anti-rabbit antibody (Promega) by ECL (Amersham
Biosciences).
CELL CYCLE ANALYSIS
Cells (3 × 105) exposed to normoxia or hypoxia were washed in
PBS and ﬁxed in ice-cold 70% ethanol for a minimum of 30 min.
Cells were centrifuged, washed in 38 mM sodium citrate (pH 7.4),
and stained for 20 min at 37◦C with 50 μg/ml propidium iodide
(Sigma) and 5 μg/ml RNase A (Sigma) in sodium citrate solution.
Cell cycle analysis was done by ﬂow cytometry using a FACScan
calibur (Becton Dickinson). The proportion of G1, G2/M peaks,
and the S phase plateau were calculated with WinMD2 software.
MEASURE OF RADIATION-INDUCED CELL DEATH
Fibroblasts (1 × 104) were seeded onto 60 mm dishes. Once
attached the medium was replaced by either HCO−3 -free or 10 mM
HCO−3 -containing DMEM buffered at an extracellular pH (also
named outside pH, pHo) of 7.0 (30 mM MES) or at pHo 7.5
(30 mM HEPES), supplemented with 10% dialyzed serum, hypox-
anthine 0.1 mM, and uridine triphosphate 0.1 mM for growth in
the absence of CO2/HCO
−
3 and transferred to a CO2-free atmo-
sphere for 24 h in the presence or absence of inhibitors [NHE-1
inhibitor HOE#694 (Hoechst) 100 μM]. Dishes were then irra-
diated (0, 2, 4, 6, 8, and 10 Gy). After irradiation, dishes were
returned to 5% CO2 in regular NaHCO3-containing medium for
5 days. Cells were then trypsinized and the percentage of cell death
was determined with trypan blue.
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CLONING EFFICIENCY
LS174Tr cells were plated in clonogenic conditions (1000 cells per
plate, triplicate) in 25 cm2 ventilated ﬂasks during 24 h, then
exposed to hypoxia (1% O2) for 48 h, and subsequently closed
with non-ventilated ﬂask caps before irradiation (0, 1, 2, 4, 6,
and 8 Gy). Cells were then returned to normoxic conditions
to allow cell recovery and determination of colony number fol-
lowing irradiation. PS120 cells were plated onto 60 mm dishes
in clonogenic conditions (1000 cells per dish, duplicate). Once
attached, cells were exposed to 30 mM HEPES, 100 μM hypoxan-
thine, 100 μM uridine, and 10% dialyzed FCS medium adjusted
to two different extracellular pH (either pHo 7.0 or 7.5) in a
CO2/HCO
−
3 free environment and subsequently irradiated (0,
1, 2, 4, 6, and 8 Gy) in these environments. Following irradia-
tion, the medium were replaced by a regular medium. Six days
(for PS120 cells) or 10 days (for LS174Tr cells) following irradi-
ation, cells were ﬁxed, stained with Giemsa, and counted using
ImageJ® software. Of note for both LS174 and PS120 cells, irra-
diation was not performed but after two or three cell divisions.
This raises the possibility of microcolony formation and over-
estimation of the number of colonies, however, we used caution
to exclude microcolonies from our ﬁnal analysis. Furthermore,
our calculations involve a ratio between experimental clones and
control. Therefore, the absolute number of clones is normal-
ized because every condition grows with the same amplitude of
error.
CELL PROLIFERATION IN THREE-DIMENSIONS AND IRRADIATION OF
SPHEROIDS
To grow spheroids, 2 × 103 cells were seeded in drops in 20 μl
of HCO−3 -free DMEM buffered with 30 mM HEPES pH 7.7 con-
taining 10% FCS. After 8 days, spheroids were irradiated (0, 2, 4,
6, and 8 Gy) as described above. Intact spheroids were then trans-
ferred to polyhema-coated 96-well plates for continued growth
in the same respective media for 4 days (12 days total growth
time including irradiation). Spheroids were dissociated in Accu-
tase (Life Technologies) and living anddead cells were immediately
counted using trypan blue exclusion.
NUDE MICE XENOGRAFTS AND IRRADIATION OF MOUSE
TUMORS
Cells (1 × 106) were subcutaneously injected into the ﬂanks
of 4-week-old male athymic nude mice (Harlan) according to
CNRS institutional guidelines and tumor growth was measured
as reported previously (Chiche et al., 2010a). A total of 750 μg/ml
doxycycline (DOX; Sigma) was added in the drinking water
before the injection of tumor cells following the previously estab-
lished protocol in our laboratory allowing us to obtain 90% of
ca9 silencing in vivo (see Chiche et al., 2010a) for immunohis-
tochemical analysis of inducible ca9 silencing in this model).
Tumors of 4–5 mm were irradiated (8 Gy) with contact X-
rays (Gérard et al., 2011) using a RT 50 Phillips unit delivering
a 50-kV maximal energy X-ray beam. The source–surface dis-
tance was 40 mm and the dose rate was 20 Gy/min. The X-ray
tube was handheld and the precision was controlled through
direct vision by the radiation oncologist using a 20-mm diameter
applicator. The dose was prescribed at the exit surface of the
applicator. One single fraction of 8 Gy was delivered into the
visible lesion.
STATISTICAL ANALYSIS
The Student’s t-test was used wherein P-values of <0.05 were
considered signiﬁcant.
RESULTS
INHIBITION OF THE MAJOR pHI-REGULATING SYSTEM NHE-1
SENSITIZES CELLS TO RADIATION-INDUCED CELL DEATH
The contribution of intracellular acidosis to cell radiosensitivity
was studied on ﬁbroblasts growing in pHo 7.5 or a more acidic
pHo 7.0 medium, in the presence or in the absence of NHE-1
inhibitor. We choose to work at pHo of 7.0 as it is low enough to
reduce the pHi compared to the pHi obtained at pHo of 7.5 but
is not low enough to prevent an observation of radiosensitization
in acidic conditions due to a reduction in cell viability caused by
acidosis alone. The impact of inhibiting NHE-1 on pHi regulation
in these cells has been well established with NHE-1 inhibition
causing a signiﬁcant reduction in pHi in a pHo of 7.0 (Pouysségur
et al., 1984). Prior to irradiation,we determined the effect of NHE-
1 inhibition on cell cycle phase distribution. Selective inhibition
of NHE-1 using HOE#694 (100 μM; see Masereel et al., 2003 for a
review of NHE inhibitors and HOE#694 effectiveness) at the more
acidic pHo 7.0 condition reduced the percentage of CCL39 cells
in the most radioresistant S phase (34% decrease of cells in the
radioresistant S phase in the presence of HOE#694 compared to
non-treated cells) while it had no effect in a more neutral pHo
7.5 medium (Figure 1A). Consistent with this ﬁnding, irradiation
of NHE-1-inhibited ﬁbroblasts in a pHo 7.0 medium led to an
increase in cell death (57% for 10Gy) compared to either untreated
cells (35% for 10 Gy; Figure 1B) or cells exposed to a pHo 7.5
medium treated or notwithHOE#694 (32% for 10Gy; Figure 1C).
EXPRESSION OF THE HYPOXIA-INDUCED pHI-REGULATING CARBONIC
ANHYDRASE IX PROTECTS CELLS AGAINST IRRADIATION
We have previously demonstrated that expression of catalytically
active CAIX in NHE-1-deﬁcient CCL39 ﬁbroblasts (PS120 cells)
maintains a higher pHi compared to control PS120 cells lacking
CAIX, when cells were exposed to a nominally bicarbonate free
acidic medium (Chiche et al., 2010a). Here we showed that in the
condition where CAIX is required for pHi regulation (pHo 7.0
compared to pHo 7.5 medium), expression of CAIX in PS120 cells
(PS120-pca9) maintains the distribution of the cell cycle phases,
while in the absence of CAIX, PS120-pev cells demonstrate a 35%
reduction in the most radioresistant S phase (Figure 2A). Conse-
quently, control PS120-pev cells growing at pHo 7.0 were shown
to be more radiosensitive than PS120-pca9 cells, with 70% cell
death following irradiation of 10 Gy for PS120-pev cells compared
to 37% for PS120-pca9 cells (Figure 2B). Of note, PS120-pca9
cells irradiated with 10 Gy at pHo 7.0 exhibited similar cell death
rates to that at pHo 7.5 while PS120-pev cells had much higher
cell death at low pHo (Figures 2B,C). Thus, active CAIX protects
cells against ionizing irradiation at low pH. To deﬁnitively validate
that the pHi-regulating functions of CAIX are indeed involved
in cellular radioprotection, PS120-pev and PS120-pca9 cells were
exposed to a pHo 7.0 medium containing 10 mM HCO
−
3 . This
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FIGURE 1 | NHE-1 protects cells against irradiation-induced cell death in
an acidic environment. (A) Cell cycle distribution of CCL39 cells treated (+)
or not (−) with 100 μM of the NHE-1 inhibitor (HOE#694) in normoxia in a
HCO−3 /CO2-free environment at pHo 7.5 or 7.0 for 24 h. (B,C) CCL39 cells
(1 × 104) were plated in 60 mm dishes. Once attached cells were incubated in
a HCO−3 -free medium adjusted to pHo 7.5 or 7.0, and treated in the presence
(+) or absence (−) of 100 μM of NHE-1 inhibitor (HOE#694) for 24 h in a
CO2-free atmosphere. Dishes were then irradiated (0, 2, 4, 6, 8, and 10 Gy)
and returned to a 5% CO2 incubator with fresh HCO
−
3 -containing medium for
4 days. Cell death was determined by the trypan blue exclusion assay.
HCO−3 addition has been shown previously to maintain pHi in
acidic pHo environments (Chiche et al., 2010a). Irradiation of
PS120-pev cells in the presence of HCO−3 reduced the percent-
age of cell death to that obtained for PS120-pca9 cells in a pHo
7.0medium(Figure 2D). Cloning efﬁciency experiments also con-
ﬁrm the capacity of irradiated cells to survive and recover following
irradiation. From 4 to 8 Gy single doses of ionizing radiation of
PS120-pev cells exposed to a pHo 7.0 medium drastically reduced
the cloning efﬁciency, compared to that observed in a pHo 7.5
medium (Figure 2E, left panel). In contrast, PS120-pca9 cells
exposed to a pHo 7.0 medium were capable to recover after irradi-
ation, to the same extent that we observed in a pHo 7.5 (Figure 2E,
right panel). Taken together these results suggest that the pHi-
regulating properties of NHE-1 and CAIX protect cells against
irradiation.
DUAL SILENCING OF THE HYPOXIA-INDUCED pHI-REGULATING-
SYSTEM ca9 /ca12 STRONGLY COMPROMISES IN VITRO AND
IN VIVO TUMOR GROWTH WHEN COMBINED WITH IONIZING
RADIATION
LS174Tr cells cultured in hypoxia before exposure to an increas-
ing dose of ionizing radiation demonstrated a higher cloning
efﬁciency than normoxic cells along with equal distribution of
cell cycle phases before irradiation (data not shown). This estab-
lished the classical radioresistance of LS174Tr cells as observed in
other hypoxic cells and validated this model for our study. In a
regular HCO−3 -containing medium a higher number of cells in
the radiosensitive G1/G2/M phases was observed when ca9 or
both ca9 and ca12 were silenced (Figure 3A). Protein expres-
sion levels of CAIX and CAXII in the Tet-inducible silencing
of ca9 in control LS174Tr cells (LS-shca9/ctl) or ca12 silenced
cells (LS-shca9/ca12−) were conﬁrmed for efﬁcient knock-down
(Figure 3A, inset). In the same conditions, ca9 or both ca9/ca12
silencing was accompanied by an increase in p21, E-cadherin, and
β1 integrin expression, which were associated with a reduced cell
proliferation (Figure 3B). To mimic both the tumor hypoxic and
proton gradient observed in vivo, we grew LS174 cells in three
dimensions. Spheroids were grown in nominally bicarbonate free
media to enhance the pH gradients that develop during spheroid
growth. Irradiation of ca9-silenced spheroids (LS-shca9/ctl +Tet,
8 Gy) revealed a cumulative decrease in the proliferation index
(Figure 3C) and a twofold increase in cell death from 27.5% (0Gy)
to 51.7% (8 Gy) when compared to non-irradiated ca9-silenced
spheroids (Figure 3D). While ca12 silencing alone did not alter
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FIGURE 2 | CAIX protects cells against irradiation-induced cell death
in an acidic environment. (A) Cell cycle distribution of NHE-1-disrupted
ﬁbroblasts PS120 cells expressing (pca9) or not (pev ) CAIX, in normoxia
in a HCO−3 /CO2-free environment at pHo 7.0 or 7.5 for 24 h. (B–D) PS120-pev
and PS120-pca9 cells (1 × 104) were plated in 60 mm dishes. Once
attached cells were incubated in 30 mM HEPES-buffered HCO−3 -free
medium adjusted to pHo 7.0 in the absence (B) or in the presence of
10 mM HCO−3 (D) or to pHo 7.5 (C) for 24 h in a CO2-free atmosphere.
Dishes were then irradiated (0, 2, 4, 6, 8, and 10 Gy) and returned to a
CO2-containing incubator with fresh regular HCO
−
3 -containing (44 mM)
medium for 4 days. Cell death was determined by the trypan blue
exclusion assay. Data represent the average of three independent
experiments. (E)The clonogenic capacity of PS120-pev and PS120-pca9
cells exposed to a medium adjusted to pHo 7.0 or 7.5 was measured
10 days after irradiation (0,1, 2, 4, 6, and 8 Gy). Dishes were stained
with Giemsa (Fluka). The colonies were counted with ImageJ software
according to the following parameters: particles size = 0.15–5 mm2 and
circularity = 0.1–1.
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FIGURE 3 | Silencing of the hypoxia-induced pHi-regulating enzymes
ca9 and ca12 induced in vitro cell death of LS174Tr cells when
combined with ionizing radiation. (A) Inset : Expression of CAIX and
CAXII in colon carcinomaTetracycline (Tet)-inducible LS-shca9/ctl −Tet
cells either silenced for ca9 (LS-shca9/ctl +Tet) or for ca12 (LS-shca9/ca12−
−Tet) or both ca9 and ca12 (LS-shca9/ca12− +Tet) in hypoxia 1% O2
(Hx) for 48 h. Hsp90 was used as a loading control. The cell cycle phase
distribution was determined by FACScan analysis of LS-shca9/ctl −/+Tet
and LS-shca9/ca12− −/+Tet cells exposed hypoxia of 1% O2 (Hx) for 24 h
in a HCO−3 -containing medium. (B) Immunoblotting of p21, β1 integrin, and
Hsp90 (loading control) in LS-shca9/ctl and LS-shca9/ca12− cells
pre-incubated for 4 days in the presence (+Tet) or absence (−Tet) of Tet
to silence ca9, before exposure to hypoxia of 1% O2 (Hx) for 48 h (H).
(C,D). Tet-inducible LS174Tr cells silenced for ca9 or ca12 or both ca9 and
ca12 were cultured as spheroids in a CO2 atmosphere and HEPES-buffered
HCO−3 -free medium (pHo 7.7 in the absence (−Tet) or presence (+Tet) of Tet
for 8 days before they were irradiated (8 Gy) or not (0 Gy). After irradiation,
spheroids were transferred to polyhema-coated 96-well plates containing
fresh medium for 5 days. Spheroids were then subjected to Accutase
dissociation and individualized live cells (C) and dead cells (D) were counted
using trypan blue. The spheroid proliferation index was calculated as the ratio
of the number of living cells counted at day 13 to the number of cells at day 0.
Data represent the average of three independent experiments. (E)The
clonogenic capacity of LS174Tr-shca9/ctl −/+Tet and LS174TR-shca9/ca12−
−/+Tet cells exposed to hypoxia (1% O2) for 48 h in a regular medium,
was measured 10 days after irradiation (0,1, 2, 4, 6, and 8 Gy). Dishes
were stained with Giemsa (Fluka). The colonies were counted with Image J
software.
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the proliferation rate of non-irradiated spheroids, irradiation of
ca12-silenced cells (LS-shca9/ca12− −Tet 8 Gy) reduced the pro-
liferation index (Figure 3C) and increased cell death from 27.5%
(0 Gy) to 37.6% (8 Gy; Figure 3D). Irradiation of double silenced
cells (LS-shca9/ca12− +Tet 8 Gy) strongly compromised prolifer-
ation and viability (75.5% cell death; Figures 3C,D). Clonogenic
test conﬁrmed that double silenced cells (LS-shca9/ca12− +Tet)
exposed to hypoxia were less capable to recover from irradiation
compared to control cells (LS-shca9/ctl −Tet) or single ca9 or
ca12-silenced cells (LS-shca9/ctl +Tet and LS-shca9/ca12− −Tet;
Figure 3E).
Using contact radiotherapy (Gérard et al., 2011), we speciﬁcally
targeted the established tumor mass grown on the back of nude
mice. Irradiation of control tumors (LS-shca9/ctl −DOX + IR)
stopped tumor progression for 5 days after irradiation before
proliferating again at a high rate, which was similar to that of
non-irradiated control tumors (LS-shca9/ctl −DOX; Figure 4A).
Tumor progression was delayed with ca-9-silencing as observed
previously while irradiation of ca9-silenced tumors (LS-shca9/ctl
+DOX +IR) showed more pronounced arrest in tumor pro-
gression (25 days after irradiation to reach 600 mm3), which
may reﬂect cell death within the tumor (Figure 4A). Irradi-
ation of ca12-silenced tumors (LS-shca9/ca12− −DOX +IR)
reduced the growth rate compared to non-irradiated tumors
(LS-shca9/ca12− −DOX) to the same extent observed for irra-
diation of control tumors suggesting that ca12 alone is not able
to confer tumor radioresistance (Figure 4B). However, irradi-
ation of double silenced tumors (LS-shca9/ca12− +DOX +IR)
showed a substantial reduction in the progression of the tumor
(33 days after irradiation to reach 600 mm3). No interaction
between DOX and irradiation was observed as shown with con-
trol LS-shev/ctl −/+DOX tumors (Figure 4C). Calculations of the
tumor growth delay for time required to reach 300 and 600 cm3,
respectively were 17.6/19.7 days (LS174shCA9 −Dox, −IR), 25.7
days/29.1 days (LS174shCA9 −Dox, +IR), 25.7 days/29 days
(LS174shCA9 +Dox, −IR) and 36 days/46.3 days (LS174shCA9
+Dox, +IR). Growth delay times for CA9/CA12 double-silencing
were 33.9 days/39.9 days (LS174shCA9/CA12 +Dox, −IR) and
36.1 days/45.9 days (LS174shCA9/CA12 +Dox, + IR). We further
calculated the speciﬁc tumor growth delay (STGD) with the fol-
lowing formula: STGD = (DT experimental − DT control)/DT
control (DT, doubling time). Irradiation alone and CA9 silencing
alone resulted in similar STGDvalues of 0.61 and0.57, respectively.
Combined irradiation and silencing of CA9 increased the STGD
to 3.9 compared to control. Meanwhile silencing of CA12 resulted
in a STGD value of 1.85 while double CA9 and CA12 silenc-
ing with irradiation had a similar STGD value to CA9 silencing
of 3.67.
These results demonstrate that silencing of ca9 and double-
silencing of ca9/ca12 combined with ionizing radiation substan-
tially decreases tumor growth in both in vitro and in vivo model
systems.
DISCUSSION
Acidosis within the tumor microenvironment arises from the
hypoxia-induced metabolic shift from oxidative phosphorylation
to glycolysis, along with the capacity of hypoxic tumor cells to
regulate their pHi through efﬁcient export of CO2 and lactic
acid. Consequently, targeting tumor pHi-regulating systems in
hypoxia holds potential as a key strategy to reduce tumor growth
(Pouysségur et al., 2006). Here we have explored a combination of
this pH disrupting strategy with radiotherapy as it was suggested
that acidosis plays a role in tumor radioresistance (Vaupel, 2004).
However, previously therewas no clear demonstrationwhether the
extracellular and/or the intracellular acidosis were responsible for
the poor radioresponse of tumor cells. Dubois et al. (2011) have
demonstrated that a combination of CAs inhibition with irradia-
tion in colon HT29 tumor-bearing mice improved the anti-tumor
effect compared to a single radiation dose. However, CA inhi-
bition did not result in increased radiosensitivity in vitro and the
contribution of the pH-regulating functions of CAIX in the tumor
radio-response remained to be clariﬁed. Herein, we demonstrate
the importance of pHi regulation in radioresistance by observing
an increase in radiation-induced cell death of ﬁbroblasts inhib-
ited for NHE-1 or lacking both NHE-1 and CAIX when they are
grown in an acidic and HCO−3 -free medium. In contrast, ectopic
expression of CAIX was able to improve cell survival following
irradiation. The mechanism of CAIX-induced radioresistance was
demonstrated with NHE-1-deﬁcient CCL39 ﬁbroblasts (PS120
cells) in a nominally CO2/HCO
−
3 free acidic environment by: (i) a
decrease in the pHi-regulating capacity of cells lacking CAIX (see
Chiche et al., 2009) and (ii) a correlation with the positioning of
these cells in the most radiosensitive G1/G2/M phases, prior to
irradiation. This cell cycle data is consistent with the reduction
in S phase entry as previously demonstrated for PS120 cells com-
pared to the parental cell line (Pouysségur et al., 1985). Expression
of CAIX prevents the reduction of cells in S phase as it allows cells
to maintain a higher pHi in acidic medium (Chiche et al., 2010a).
With addition of HCO−3 /CO2 in low pH medium (pHo 7.0) we
observed no difference in cell death between irradiated-PS120-
pev and irradiated-PS120-pca9 cells due to the buffering ability of
HCO−3 /CO2 to restore alkaline pHi values as previously demon-
strated (Chiche et al., 2010a). We conclude that the CAIX-induced
protection against irradiation at pHo 7.0 could be explained
by the capacity of CAIX to sustain an intracellular alkaline
shift.
Under three-dimensional growth conditions that result in
hypoxia (Chiche et al., 2010a; Pelletier et al., 2012) and acidosis
(Swietach et al., 2010), LS174Tr spheroids silenced for ca9/ca12
showed a decrease in proliferation and a cumulative increase in
cell death (75%) after a single radiation dose. Double silenced
cells were indeed most sensitive to irradiation, since: (i) combined
silencing reduced the capacity of LS174Tr cells to regulate their pHi
in acidic medium while single silencing of ca9 was not sufﬁcient to
do so (Chiche et al., 2010a), (ii) silencing of ca9/ca12 increased p21
expression indicating a cell cycle arrest in G1 along with increased
levels of β1 integrin, two key proteins involved in cell contact
and adhesion which may inﬂuence proliferation (Svastová et al.,
2003) and (iii) ca9 silencing lead to a reduction in proliferation
and a decrease in cell number in the radioresistant S phase. A
single radiation dose on xenograft tumors dramatically reduced
the growth rate of ca9- and ca9/ca12-silenced tumors. Twenty-ﬁve
days after irradiation, ca9-silenced tumors recovered a growth rate
that was comparable to control tumors, while ca9/ca12-silenced
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“fonc-02-00199” — 2013/1/4 — 18:28 — page 8 — #8
Doyen et al. CAIX/CAXII contribute to tumor radioresistance
FIGURE 4 | Combined silencing of ca9 and ca12 compromises in vivo
LS174Tr cell proliferation when combined with ionizing radiation.
(A,B). Anti-tumor activity of silencing ca9 or ca12 individually or combined is
increased in conjunction with ionizing radiation in LS174Tr xenograft tumors.
At 4 days before injection of LS-shca9/ctl (A) or LS-shca9/ca12− cells (B),
cells were incubated with or without Tet (+/−Tet) to silence ca9. In vivo
xenograft assays were performed by s.c injection of viable and individual
tumor cells (1 × 106) into the ﬂanks of athymic nude mice. To maintain
ca9 knock-down mice received DOX in the drinking water 4 days before
cell injection. Fifteen days after cell injection, when the tumor size reached
4–5 mm, a single dose (8 Gy) of irradiation (IR) was delivered to the tumors
only with “contact X-rays.” Xenograft growth was determined by measuring
the tumor volume. (C) Xenograft tumor growth of control tumors LS-shev/ctl
irradiated (IR) or not, in the presence (+DOX) or in the absence (−DOX) of
doxycycline in the drinking water. Five mice were used per
condition.
and irradiated tumors never recovered the growth rate of con-
trol cells. In addition, the loss of radioresistant hypoxic cells
due to CA9/CA12 silencing could contribute to the reduction of
tumor growth in combination with their radio-sensitivity due to
decreased pHi regulation.
Hypoxia-speciﬁc cytotoxins such as tirapazamine form toxic
radical species that act to kill hypoxic cells and are thus proposed
to be used in combination with irradiation to create a synergistic
effect (Brown, 1993). Unfortunately this treatment-strategy failed
to be efﬁcient in patients (Rischin et al., 2010). Intense research
Frontiers in Oncology | Molecular and Cellular Oncology January 2013 | Volume 2 | Article 199 | 8
“fonc-02-00199” — 2013/1/4 — 18:28 — page 9 — #9
Doyen et al. CAIX/CAXII contribute to tumor radioresistance
is ongoing in the development of small molecule inhibitors to
speciﬁcally target membrane-bound CA(s) over cytosolic CAs to
appraise the potential of targeting CAIX and CAXII to decrease
tumor progression (Morris et al., 2011). The synthesis of new
CA(s) inhibitors (Supuran, 2008; Morris et al., 2011) has also
revived interest in acetazolamide (ACTZ), which has been used
in the clinic for over 40 years as a CA inhibitor (Kaur et al.,
2002). Recently, ACTZ was linked to a C-terminal albumin-
binding peptide (Albu-ACTZ) with the aim of not only reducing
blood clearance but also preventing internalizationof themolecule
to target more speciﬁcally membrane-bound CAIX and CAXII.
This compound demonstrated its in vivo efﬁcacy by retarding
tumor growth of renal SK-RC-52 xenografts. However, it had
no signiﬁcant impact on highly proliferative LS174Tr tumors
(Ahlskog et al., 2009).
In the present study, we took advantage of the expression of
the hypoxia-induced pHi-regulating systems CAIX and CAXII to
target radioresistant hypoxic cells. This study reinforces the notion
that CAIX and CAXII represent potential targets for anti-cancer
treatment. The present study also supports the use of radiotherapy
in combination with CAs inhibition as a new anti-cancer strategy.
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